BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease

American Journal of the Medical Sciences

Volumn 339, Issue 1, 2010, Pages 10-14

  Faganello, Márcia Maria ^a   Tanni, Suzana Erico ^b   Sanchez, Fernanda Figueirôa ^c   Pelegrino, Nilva Regina Gelamo ^b   Lucheta, Paulo Adolfo ^b   Godoy, Irma ^b  

^a School of Medicine   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c Faculdades Adamantinenses Integradas   (Brazil)

Author keywords

Age; BODE index; COPD exacerbation; GOLD stage; Hypoxemia

Indexed keywords

ADULT; AGE; AGED; AIRWAY OBSTRUCTION; AREA UNDER THE CURVE; ARTICLE; BODE INDEX; BODY COMPOSITION; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; CONFIDENCE INTERVAL; DEMOGRAPHY; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EXERCISE; FEMALE; FOLLOW UP; GOLD STAGING; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OXYGEN SATURATION; PREDICTION; PREDICTOR VARIABLE; QUALITY OF LIFE; RATING SCALE; RISK; RISK FACTOR; SPIROMETRY; WALKING;

EID: 75449094834     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181bb8111     Document Type: Article

References (36)

1. Rabe KF, Hurd S, Anzueto A, et al. GOLD-global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-555
2. Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-852
3. Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease-results from the Lung Health Study. Am J Respir Crit Care Med 2001;164:358-364
4. Miravitlles M, Ferrer M, Pont A, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004;59:387-395
5. Wang QY, Bourbeau J. Outcomes and health-related quality of life following hospitalization for an acute exacerbation of COPD. Respirology 2005;10:334-340
6. Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996;154:959-967
7. Oostenbrink JB, Molken M. Resource use and risk factors in highcost exacerbations of COPD. Respir Med 2004;98:883-891
8. Holgate ST. Priorities for respiratory research in the UK. Thorax 2007;62:5-7.
9. Garcia-Aymerich J, Monso E, Marrades RM, et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation- EFRAM Study. Am J Respir Crit Care Med 2001;164:1002-1007
10. Ong KC, Earnest A, Lu SJ. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 2005; 128:3810-3816
11. Niewoehner DE, Lokhnygina Y, Rice K, et al. Risk indexes for exacerbations and hospitalizations due to COPD. Chest 2007;131:20-28
12. Marin JM, Carrizo SJ, Casanova C, et al. Prediction of risk of COPD exacerbation by BODE index. Respir Med 2009;103:373-378
13. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012
14. Soler-Cataluña JJ, Martinez-Garcia MA, Sánchez LS, et al. Severe exacerbation and BODE index: two independent risk factor for death in male COPD patients. Respir Med 2009;103:692-699
15. Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered outcomes. Chest 2007;131:696-704.
16. Pitta F, Breyer M-K, Hernandes NA, et al. Comparison of daily physical activity between COPD patients from Central Europe and South America. Respir Med 2009;103:421-426
17. Fabbri LM, Hurd SS. Global strategy for the diagnosis, management and prevention of COPD: 2003. Eur Respir J 2003;22:1-2.
18. Jardim J, Oliveira J, Nascimento O. II Consenso Brasileiro de DPOC. J Bras Pneumol 2004;30:S1-S42.
19. American Thoracic Society Statement. Standardization of spirometry- 1987 update. Am Rev Respir Dis 1987;136:1285-1298
20. Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-734
21. Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 2004;23: 1430-1453
22. Kyle UG, Pichard C, Rochat T, et al. New bioelectrical impedance formula for patients with respiratory insufficiency: comparison to dualenergy X-ray absorptiometry. Eur Respir J 1998;12:960-966
23. Schols A, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005;82:53-59
24. Sousa T, Jardim J, Jones P. Validação do questionário do hospital Saint George na doença respiratória (SGRQ) em pacientes portadores de doença pulmonar obstrutiva crônica no Brasil. J Bras Pneumol 2000;26:119-125
25. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580-586
26. Crapo RO, Casaburi R, Coates AL, et al. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117
27. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-1251
28. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117:398S- 401S.
29. Garcia-Aymerich J, Farrero E, Felez MA, et al. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003;58:100-105
30. Miravitlles M, Murio C, Guerrero T. Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. Eur Respir J 2001;17:928-933
31. Miravitlles M, Guerrero T, Mayordomo C, et al. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. Respiration 2000;67:495-501.
32. Foreman MG, DeMeo DL, Hersh CP, et al. Clinical determinants of exacerbations in severe, early-onset COPD. Eur Respir J 2007;30: 1124-1130
33. McKellar A, Cottrell WN, Whelan A. BODE score is a useful predictor of hospital admission in rural patients with chronic obstructive pulmonary disease. Respirology 2008;13:438-443
34. Au DH, Bryson CL, Chien JW, et al. The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations. J Gen Intern Med 2009;24:457-463
35. Wedzicha J, Calverley P, Seemungal T, et al. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/ fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008;177:19-26.
36. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-1422